Alaunos Therapeutics Statistics
NASDAQ: TCRTHealth CareBiotechnology: Pharmaceutical PreparationsUSD
0.7858+0.0048 (+0.61%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Alaunos Therapeutics by the numbers
Alaunos Therapeutics has a market capitalization of $2.3 million based on 2.93M shares outstanding. With trailing EPS of $-1.76, Alaunos Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 48.6% below its 50-day average and 67.4% below its 200-day average.
Average daily trading volume is 809.68K shares, or about $636,246 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
TCRT valuation vs. peer median
| Metric | TCRT | Peer median | Difference |
|---|---|---|---|
| Market cap | $2.30M | $2.36M | -3% |
| Avg. volume | 809.68K | 321.86K | +152% |
Peer median across 8 companies: GNPX, PPBT, ELAB, OGEN, XRTX, SPRC, KAPA, LABT.
Valuation
- Market cap
- $2.30M
- EPS (TTM)
- $-1.76
- Shares outstanding
- 2.93M
Price and trading
- Previous close
- 0.781
- Open
- 0.804
- Day range
- 0.78 – 0.804
- 52-week range
- 0.72 – 4.50
- Beta
- —
- Volume
- 41.05K
- Average volume
- 809.68K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Aug 14, 2025
Additional statistics
- Market Cap
- 2.30M
- Forward Pe
- -1.31
- Eps
- -1.76
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 4.50
- Week52 Low
- 0.72
- Avg Volume
- 809.68K
- Shares Outstanding
- 2.93M
- Ma50
- 1.53
- Ma200
- 2.41
- Earnings Date
- Aug 14, 2025
- Pct From52w High
- -82.54%
- Pct From52w Low
- 9.14%